{"title":"Dose-dependent ventricular lesion formation using a novel large-area pulsed field ablation catheter: A preclinical feasibility study","authors":"Thomas Kueffer PhD , Daniela Casoni DVM, PhD , Christine Goepfert DVM, PhD , Olgica Beslac , Chiara Parodi DVM , David Ramirez PhD , Kara Garrott PhD , Brendan Koop PhD , Sean Coe MSc , Nathan Hagstrom PhD , Guillaume Gibert MSc , Laurent Roten MD , Andreas Haeberlin MD, PhD , Tobias Reichlin MD","doi":"10.1016/j.hrthm.2025.02.017","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Pulsed field ablation (PFA) has shown promising data in terms of safety and procedural efficiency for pulmonary vein isolation. Large-area focal PFA catheter designs might be suitable to deliver deep and durable lesions in ventricular myocardium.</div></div><div><h3>Objective</h3><div>We aimed to investigate the dose-response of a novel large-area focal 3-dimensional (3D)–enabled map-and-ablate PFA catheter for ventricular ablation in a chronic preclinical swine model.</div></div><div><h3>Methods</h3><div>An 8F catheter with a 9-mm hexaspline tip was used for 3D mapping of both ventricles in a porcine model. Using a PFA generator with a proprietary waveform optimized for the catheter, left and right ventricular lesions were placed with either a monopolar or bipolar ablation vector and with 1, 2, or 4 applications per site (2.0 kV/application). Tissue contact was ensured by intracardiac echocardiography and electrograms. The animals were kept alive for 1 week. Ablation lesions were assessed macroscopically after triphenyl tetrazolium chloride staining and by histopathology.</div></div><div><h3>Results</h3><div>A total of 69 chronic ventricular lesions from 7 pigs were available for analysis. By stacking 4 PFA applications rather than a single application, median chronic lesion depth increased from 4.8 mm (interquartile range [IQR], 4.1–5.6 mm) to 5.5 mm (IQR, 5.0–6.2 mm; <em>P</em> = .06) with bipolar ablation and from 4.9 mm (IQR, 4.4–5.2 mm) to 6.5 mm (IQR, 5.9–6.9 mm; <em>P</em> = .002) with monopolar ablation. On histologic evaluation, lesion borders were clearly demarcated, with vessels and nerves preserved.</div></div><div><h3>Conclusion</h3><div>A novel large-area focal ablation catheter with the ability for 3D mapping and PFA was able to create dose-dependent deep ventricular lesions durable 1 week after ablation.</div></div>","PeriodicalId":12886,"journal":{"name":"Heart rhythm","volume":"22 9","pages":"Pages 2322-2330"},"PeriodicalIF":5.7000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heart rhythm","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1547527125001420","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/11 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Pulsed field ablation (PFA) has shown promising data in terms of safety and procedural efficiency for pulmonary vein isolation. Large-area focal PFA catheter designs might be suitable to deliver deep and durable lesions in ventricular myocardium.
Objective
We aimed to investigate the dose-response of a novel large-area focal 3-dimensional (3D)–enabled map-and-ablate PFA catheter for ventricular ablation in a chronic preclinical swine model.
Methods
An 8F catheter with a 9-mm hexaspline tip was used for 3D mapping of both ventricles in a porcine model. Using a PFA generator with a proprietary waveform optimized for the catheter, left and right ventricular lesions were placed with either a monopolar or bipolar ablation vector and with 1, 2, or 4 applications per site (2.0 kV/application). Tissue contact was ensured by intracardiac echocardiography and electrograms. The animals were kept alive for 1 week. Ablation lesions were assessed macroscopically after triphenyl tetrazolium chloride staining and by histopathology.
Results
A total of 69 chronic ventricular lesions from 7 pigs were available for analysis. By stacking 4 PFA applications rather than a single application, median chronic lesion depth increased from 4.8 mm (interquartile range [IQR], 4.1–5.6 mm) to 5.5 mm (IQR, 5.0–6.2 mm; P = .06) with bipolar ablation and from 4.9 mm (IQR, 4.4–5.2 mm) to 6.5 mm (IQR, 5.9–6.9 mm; P = .002) with monopolar ablation. On histologic evaluation, lesion borders were clearly demarcated, with vessels and nerves preserved.
Conclusion
A novel large-area focal ablation catheter with the ability for 3D mapping and PFA was able to create dose-dependent deep ventricular lesions durable 1 week after ablation.
背景:脉冲场消融(PFA)在肺静脉隔离(PVI)的安全性和程序效率方面显示出有希望的数据。大面积局灶PFA导管设计可能适合递送心室心肌的深度和持久病变。目的:研究一种新型的大面积3d定位消融PFA导管在慢性临床前猪模型中用于心室消融的剂量反应。方法:采用8f导管,尖端为9mm的六棱线,对猪脑室模型进行三维定位。使用PFA发生器(FARASTAR, Boston Scientific),采用针对导管优化的专有波形,将左室和右室病变放置在单极或双极消融矢量上,每个位置有1、2或4个应用(2.0 kV/应用)。通过心内超声和心电图检查确保组织接触。动物存活1周。经三苯四氮氯化染色和组织病理学观察消融病变。结果:7头猪共69例慢性心室病变可用于分析。通过将4个PFA应用叠加而不是单个应用,双极消融中位慢性病变深度从4.8 mm (IQR 4.1-5.6)增加到5.5 mm (IQR 5.0-6.2), p=0.06,单极消融从4.9 mm (IQR 4.4-5.2)增加到6.5 mm (IQR 5.9-6.9), p=0.002。组织学上病灶边界清晰,保留血管和神经。结论:一种具有3d定位和脉冲场消融能力的新型大面积局灶消融导管能够在消融后1周产生剂量依赖性的深心室病变。
期刊介绍:
HeartRhythm, the official Journal of the Heart Rhythm Society and the Cardiac Electrophysiology Society, is a unique journal for fundamental discovery and clinical applicability.
HeartRhythm integrates the entire cardiac electrophysiology (EP) community from basic and clinical academic researchers, private practitioners, engineers, allied professionals, industry, and trainees, all of whom are vital and interdependent members of our EP community.
The Heart Rhythm Society is the international leader in science, education, and advocacy for cardiac arrhythmia professionals and patients, and the primary information resource on heart rhythm disorders. Its mission is to improve the care of patients by promoting research, education, and optimal health care policies and standards.